ATAI
AtaiBeckley Inc. Common Stock
stockNASDAQ
InactiveSep 10, 2026
7.35USD+0.823%(+0.06)9,587,449
Loading…
Loading…
Sector
Consumer Defensive
Industry
Education
HQ
Berlin, Berlin, Germany
Sep 8, 2026
Lilly Builds Neuroscience into a New Long-Term Growth Driver · 
Zacks Investment Research
ATAI Profile
who we are: atai is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. our mission: we are committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space. our approach: by pooling expertise, best practices, and resources across our entire portfolio, we mitigate risk and responsibly accelerate the development of impactful and evidence-based treatments.
ATAI Performance
| Period | Price | Date | Change |
|---|